Regenerative Medicine: Next Generation Treatments
Wednesday, February 8, 2017 — 9:30 a.m. - 11:30 a.m.
Full conference registration is required to attend this session.
Session Chairs:
G. Sitta Sittampalam, Ph.D.
Senior Advisor to the Director, Immediate Office of the Director
National Center for Advancing Translational Sciences
National Institutes of Health
Marcie Glicksman Ph.D.
Chief Scientific Officer
ORIG3N, INC.
Regenerative medicine is having a big impact on the future of medicine. It has the potential to fully repair damaged cells, tissues and organs. Developments in stem cell technology, tissue engineering and molecular biology are pushing the frontiers of medicine by providing the possibility of cures through the use of cellular therapies. The next decade will see the rapid development of treatments that will employ human iPS cells, drugs and biologics as substrates for therapies in acute and chronic diseases. In this session, presentations will represent the recent advances in the generation, standardization, characterization and the mechanistic behavior of stem cells and their applications in regenerative medicine.
Presentations include:
- Progress and Challenges in Translational iPS Cell Research — Ilyas Singec, Director, Stem Cell Translation Laboratory, NIH/NCATS, Rockville, MD, USA
- Angiopellosis as an Alternative Mechanism of Cell Extravasation — Ke Cheng, Associate Professor, NC State University/UNC-Chapel Hill, Raleigh, NC, USA
- Modeling Developmental Brain Disorders Using Patient-Derived Induced Pluripotent Stem Cells — Hongjun Song, Professor, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Standardized Generation of Patient-Specific and Gene-Corrected Induced Pluripotent Stem Cell Lines for Disease Modeling and Drug Screening — Lise Munsie, Development Scientist, CCRM, Toronto, ON, Canada
